U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07836010) titled 'Suzetrigine Added to Multimodal Analgesia for Women Undergoing Minimally Invasive Hysterectomy' on Sept. 17.
Brief Summary: This study will assess the analgesic efficacy of suzetrigine as part of a multimodal analgesic regimen in women undergoing laparoscopic or robotic hysterectomy. Outcomes will be compared with matched historical controls receiving the current ERAS regimen without suzetrigine.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Postoperative Pain
Intervention:
DRUG: Suzetrigine
Suzetrigine is an oral non-opioid pain medication used to treat moderate-to-severe acute pain in adults.
Recruitm...